ReviewEJNMMI research2026

Glypican-3 targeted radiopharmaceuticals for hepatocellular carcinoma: a review of molecular platforms.

Yue Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.